All authors contributing manuscripts for consideration for publication in Formulary must disclose any real or apparent conflicts of interest due to affiliation with any company or manufacturer whose products are mentioned in the article they author.
Novo Nordisk Terminates Collaboration with Hims & Hers
June 23rd 2025The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide products. Novo Nordisk said that Hims & Hers continues to offer these compounded drugs.
Read More